Previous studies have found less than 40% of patients with stable chest pain undergoing invasive coronary angiography are found to have obstructive coronary artery disease. Recent randomized clinical… read more.
To treat depression in heart failure, patients can receive with similar efficacy either behavioral activation psychotherapy or antidepressant drug therapy, researchers report. The findings appeared on Jan.17, 2024… read more.
Boston Scientific Corporation announced it has received FDA approval for the Farapulse Pulsed Field Ablation (PFA) System. The Farapulse PFA System is indicated for the isolation of pulmonary… read more.
Subjects from a weight loss trial who achieved any remission from Type 2 diabetes also achieved a 40% lower rate of cardiovascular disease (CVD) and a 33% lower… read more.
Most stroke survivors were able to safely take two types of common antidepressants, according to a preliminary study to be presented at the American Stroke Association’s International Stroke Conference… read more.
Artery calcification is almost twice as common in people who stay up late, according to a study from the University of Gothenburg, Sweden. The scientists found that circadian function… read more.
Esperion announced that the FDA has approved an updated LDL-cholesterol lowering indication for Nexletol and Nexlizet to include the treatment of primary hyperlipidemia as a qualifier for existing… read more.
People who live in neighborhoods with higher levels of poverty and unemployment are less likely to fill their heart-failure drug prescriptions than those living in wealthier areas, a… read more.
Medtronic plc announced that the FDA has approved the PulseSelect Pulsed Field Ablation (PFA) System for the treatment of both paroxysmal and persistent atrial fibrillation (AF). This is… read more.
Despite an end to the national public health emergency in May 2023, the use of telehealth remains high, with over 20% of American adults taking appointments online. These visits include… read more.
As the use of wearable technology grows, smart watches are marketed across the globe to consumers as a way to monitor health. For some, they’re told by these… read more.
Amgen announced new data reinforcing the safety and efficacy of Repatha (evolocumab) from the FOURIER Open Label Extension (OLE) [FOURIER-OLE] trial at the American Heart Association (AHA) Scientific… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
